ALung is now proud to be part of LivaNova.

ALung Technologies, Inc. is now part of LivaNova

May 2, 2022 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, has been acquired by LivaNova and will be part of its Advanced Circulatory Support business unit. For more information on LivaNova, please visit